Scinovex
article Open Access

A unique case report of successful pregnancy and delivery after being treated with pioglitazone and glimepiride (In first three months)

International Journal of Applied Research · 2021 · Vol. 7(7) · pp. 114–115
Nirmalya RoySuman SarkarAnkan PathakNikhil Sonthalia

Abstract

A planned pregnancy (with IVF) in a patient with type 2 diabetes was treated with insulin along with glimepiride and pioglitazone (treated in first three months) from pre-conception stages until the postpartum is reported. She delivered a single viable male child at 33 weeks of gestation due to pregnancy induced hypertension and type 2 diabetes mellitus with no abnormalities. The newborn was healthy without any congenital and other abnormalities. To our belief, this is the first case reporting the use of pioglitazone as well as glimepiride in early pregnancy. It should be noted that both of the drugs are not recommended to be used in pregnancy but we may come across situations where the patient is already exposed to these drugs and not willing to abort pregnancy and this case adds value to the existing body of medical literature in such cases.

Pregnancy and preeclampsia studiesGestational Diabetes Research and ManagementDiabetes Treatment and ManagementPioglitazoneGlimepirideMedicinePregnancyObstetricsGestationDiabetes mellitusType 2 diabetesGynecologyEndocrinology
Citations
0
FWCI
0.00
field-weighted impact
References
6
Percentile
11%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

A unique case report of successful pregnancy and delivery after being treated with pioglitazone and glimepiride (In first three months) · Scinovex